Application of membranaceous beautyleaf root extract in kidney protection

The Hengjingxi extract preparation method addresses the underutilization of its medicinal properties by enhancing kidney protection through reducing renal edema and promoting glomerular filtration rate, leveraging micro-boiling extraction and filtration techniques.

CN119074794APending Publication Date: 2024-12-06GUANGXI WUZHOU PHARMA GRP
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202310661939.1
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2023-06-06
Publication Date
2024-12-06

AI Technical Summary

Technical Problem

There is a lack of comprehensive utilization and understanding of the medicinal properties of Hengjingxi, limiting its development beyond anti-inflammatory and analgesic effects.

Method used

A method for preparing a Hengjingxi extract by micro-boiling extraction using purified water, followed by filtration and dilution with cold boiled water, to enhance its application in kidney protection, specifically reducing renal edema and promoting glomerular filtration rate.

Benefits of technology

The extract effectively reduces renal edema incidence and promotes glomerular filtration rate, demonstrating its potential as a kidney-protective agent.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119074794A_ABST
    Figure CN119074794A_ABST
Patent Text Reader

Abstract

The invention discloses an application of a membranaceous beautyleaf root extract in kidney protection. The membranaceous beautyleaf root extract is prepared by the following steps: crushing membranaceous beautyleaf root medicinal materials, adding purified water into the obtained medicinal powder, performing micro-boiling extraction and filtration, adding purified water into medicine residues, continuously performing micro-boiling extraction, performing filtration, combining two extracting solutions, and adding cold boiled water for quantification, thereby obtaining the membranaceous beautyleaf root extract. The membranaceous beautyleaf root medicinal materials comprise membranaceous beautyleaf root stems, branches and leaves or seeds. The membranaceous beautyleaf root extract disclosed by the invention has the effect of protecting the kidney and can be used for preparing a medicine for protecting the kidney.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of drug extraction and application, and particularly relates to application of a Herba Lycopodii Extract in kidney protection. Background Art

[0002] Hengjingxi, also known as thin-leaved Hutong, comb wood, basket king, thin-leaved red thick shell, bone-breaking general, broken bone lotus, yellow leather, unicorn wind, etc., is often used as medicine with its roots and leaves. It is slightly bitter and flat in nature. It has the functions of removing rheumatism, strengthening muscles and bones, promoting blood circulation and relieving pain. It has a very broad medicinal prospect. It mainly grows in Guangdong and Guangxi and other places.

[0003] There are not many studies on the pharmacological effects of Hengjingxi. Wei Jianquan et al.'s "Experimental Study on the Anti-inflammatory and Analgesic Effects and Acute Toxicity of Hengjingxi" disclosed that Hengjingxi has anti-inflammatory and analgesic effects, and used modern pharmacological methods to conduct experimental studies on the anti-inflammatory and analgesic effects and acute toxicity of its extracts. At present, there are no reports on other medicinal uses of Hengjingxi. In view of the preciousness of Hengjingxi medicinal materials, how to further develop its more medicinal functions and realize the comprehensive utilization of Hengjingxi medicinal materials resources is a technical problem that needs to be solved. Summary of the invention

[0004] The present invention aims to provide an application of a Hengjingxi extract in kidney protection.

[0005] The technical solution of the present invention: an application of a Hengjingxi extract in kidney protection, characterized in that the Hengjingxi extract is prepared by the following steps: taking the Hengjingxi medicinal material and crushing it, adding purified water to the obtained powder for micro-boiling extraction, filtering, adding purified water to the residue to continue micro-boiling extraction, filtering, combining the two extracts, adding cold boiled water for a certain amount, and obtaining the Hengjingxi extract.

[0006] Preferably, the Hengjingxi extract is prepared by the following steps: crushing the Hengjingxi medicinal material, adding 5 times the amount of purified water to the obtained powder for extraction, keeping it slightly boiling for 30 minutes, filtering, adding 2 to 3 times the amount of purified water to the residue for further extraction, keeping it slightly boiling for 20 minutes, filtering, combining the two extracts, adding cold boiled water to quantify to 5 times the amount of the original powder, and obtaining the Hengjingxi extract.

[0007] Preferably, the Hengjingxi is the rhizome, branches, leaves or seeds of the Hengjingxi medicinal material.

[0008] Preferably, the kidney protection is specifically manifested in that the rhizomes and seeds of the Herba Lycopodii can reduce the incidence of renal edema and promote glomerular filtration rate.

[0009] Preferably, the specific manifestation of the renal protection is that the branches and leaves of the Herba Lycopodii can reduce the incidence of renal edema, but do not significantly promote the glomerular filtration rate.

[0010] The beneficial technical effect of the present invention is that the extract of the Radix Achyranthis Bidentatae provided by the present invention has the effect of protecting the kidney and can be used to prepare drugs for protecting the kidney. BRIEF DESCRIPTION OF THE DRAWINGS

[0011] Figure 1 This is a typical picture of zebrafish renal edema after treatment with the cross-sectional sample (Note: the arrow points to renal edema).

[0012] Figure 2 A typical graph of the whole-body fluorescence intensity of zebrafish after transverse mat sample treatment. DETAILED DESCRIPTION

[0013] The following is further described with reference to examples, but the present invention is not limited to these examples. Example

[0014] Take the rhizome, branches, leaves or seeds of Hengjingxiong and grind them separately, then weigh 10 g of the obtained powder and add 50 mL of purified water for extraction, keep it slightly boiling for 30 min, filter the obtained residue and add 20-30 mL of purified water to continue extraction, keep it slightly boiling for 20 min, filter, combine the two extracts, add cold boiled water to quantify to 50 mL, and you can get a Hengjingxiong extract with a content of 0.2 g / mL (each milliliter of extract is equivalent to 0.2 g of crude drug).

[0015] The following is an experimental example of establishing a zebrafish animal model to further illustrate the application of the extract of Rhizoma Cynomorii in kidney protection, but the present invention is not limited to these experimental examples.

[0016] 1. Experimental Animals Wild-type AB strain zebrafish were bred in natural pairs and provided by the fish breeding center of Hangzhou Huante Biotechnology Co., Ltd. Zebrafish aged 2 days post fertilization (2 dpf) were used for the determination of the maximum detection concentration (MTC) of the sample's renal protective efficacy and its efficacy evaluation.

[0017] 2. Sample preparation information The extract of the Radix Achyranthis Bidentatae obtained in the example was used as the mother solution, which was packaged and stored at -20°C. During the experiment, purified water was used to prepare sample solutions of high, medium and low concentrations.

[0018] Positive control: Weigh the white powder of dexamethasone, prepare a 9.81 mg / mL stock solution with dimethyl sulfoxide, and store at -20°C.

[0019] 3. Detection Methods (1) MTC determination 2 dpf wild-type AB strain zebrafish were randomly selected in 6-well plates, and 30 zebrafish were treated in each well. Different concentrations of rhizomes, branches and leaves of A. truncatum were given water-soluble, and normal control group and model control group were set up at the same time. The volume of each well was 3 mL. Except for the normal control group, the rest of the experimental groups were given aristolochic acid A in water-soluble to establish the zebrafish renal injury model. After treatment at 28℃ for 48 h, the MTC of A. truncatum samples on the renal injury model zebrafish was determined.

[0020] (2) Evaluation of renal protective efficacy (phenotype observation) 2 dpf wild-type AB strain zebrafish were randomly selected in 6-well plates, and 30 zebrafish were treated in each well. Different concentrations of rhizomes, branches and leaves of P. truncatum, and seeds of P. truncatum were administered with water solution, and the positive control was dexamethasone at a concentration of 9.81 μg / mL. A normal control group and a model control group were also set up, with a volume of 3 mL per well. Except for the normal control group, all other experimental groups were administered with aristolochic acid A in water solution to establish a zebrafish renal injury model. After treatment at 28℃ for 48 h, the renal edema of zebrafish in each experimental group was observed under a dissecting microscope and the incidence was statistically calculated. The renal protective efficacy of P. truncatum samples was evaluated by the statistical analysis results of this index.

[0021] (3) Evaluation of glomerular filtration promoting efficacy 2 dpf wild-type AB strain zebrafish were randomly selected in 6-well plates, and 30 zebrafish were treated in each well. Different concentrations of rhizomes, branches and leaves of P. truncatum were administered with water solution, and the positive control was dexamethasone at a concentration of 9.81 μg / mL. A normal control group and a model control group were also set up, with a volume of 3 mL per well. Except for the normal control group, all other experimental groups were administered with water solution of aristolochic acid A to establish a zebrafish renal injury model. After 24 h of treatment at 28℃, the fluorescent marker (Dextran tetramethylrhodamine) was injected into the blood circulation system of zebrafish in each experimental group. After 24 h of treatment, 10 zebrafish were randomly selected from each experimental group and photographed under a fluorescence microscope. The data were analyzed and collected using NIS-Elements D 3.20 advanced image processing software. The whole-body fluorescence intensity of zebrafish was analyzed, and the statistical analysis results of this index were used to evaluate the promoting effect of P. truncatum samples on glomerular filtration. The statistical analysis results were expressed as mean ± SE.

[0022] 4. Statistical methods Statistical analysis The results were analyzed using SPSS 26.0 software. P < 0.05 indicated that the difference was statistically significant.

[0023] 5. Experimental Results (1) MTC As shown in Table 1, under the experimental conditions, the MTC of kidney protection effect of rhizomes and branches and leaves of P. raphani was 125 μg / mL, and the MTC of kidney protection effect of P. raphani seeds was 250 μg / mL.

[0024]

[0025] (2) Evaluation of renal protective efficacy (phenotype observation) In both humans and zebrafish, aristolochic acid can induce renal edema and renal dysfunction, causing irreversible renal damage or even death. Taking advantage of the transparent nature of zebrafish larvae, after treatment with aristolochic acid, ① the characteristic phenotype of renal edema can be directly observed with the naked eye or under a microscope; ② by exogenously injecting red fluorescent substances into the circulatory system, zebrafish with glomerular filtration dysfunction cannot excrete the fluorescent substances, so the glomerular filtration function can be analyzed by observing the red fluorescence intensity of the zebrafish body.

[0026] Under the experimental conditions, compared with the normal control group, the number of renal edema in the model control group increased significantly, with statistically significant differences ( P < 0.001), the incidence of renal edema was 100%, indicating that the model was successfully established; compared with the model control group, the number of renal edema in the positive drug dexamethasone group was significantly reduced, with statistically significant differences ( P < 0.001), the incidence of renal edema was 7%; the number of renal edema in the 31.2, 62.5, and 125 μg / mL concentration groups of the rhizome of the stratum sibiricum was significantly reduced compared with the model control group, with statistically significant differences (all P < 0.001), the incidence of renal edema was 60%, 57% and 7% respectively; the number of renal edema in the 31.2, 62.5 and 125 μg / mL concentration groups of the leaves and branches of the horizontal meridian was less than that in the model control group, with statistically significant differences ( P < 0.05 & P < 0.05 & P < 0.001), the incidence of renal edema was 80%, 80% and 37% respectively; the number of renal edema in the 62.5, 125, and 250 μg / mL concentration groups of Xanthophyllum sibiricum seeds was significantly lower than that in the model control group ( P < 0.05 & P < 0.05 & P < 0.01), the incidence of renal edema was 77%, 77% and 70% respectively. Figure 1 and Table 2.

[0027]

[0028] (3) Evaluation of glomerular filtration efficacy Under the experimental conditions, compared with the normal control group, the fluorescence intensity of zebrafish in the model control group increased significantly, with statistically significant differences ( P < 0.001), indicating that the model was successfully established; compared with the model control group, the positive drug dexamethasone can significantly reduce the fluorescence intensity of the zebrafish body, with statistically significant differences ( P < 0.001), the whole body fluorescence intensity of zebrafish in the 125 µg / mL concentration group of rhizomes of the horizontal meridian was significantly reduced compared with the model control group, with statistically significant differences ( P < 0.001), the whole body fluorescence intensity of zebrafish in the 62.5, 125 and 250 µg / mL concentration groups of the seeds of the genus Pinnata was lower than that in the model control group, with statistically significant differences ( P < 0.05 & P < 0.05 & P < 0.01). Figure 2 and Table 3.

[0029]

[0030] 6. Experimental Conclusion The three samples of the same concentration of the genus Atractylodes lancea were compared to reduce the incidence of renal edema: (1) at 31.2 µg / mL, there was no significant difference in the incidence of renal edema, but the incidence of renal edema in the rhizomes of the genus Atractylodes lancea was lower than that in the branches and leaves of the genus Atractylodes lancea; (2) at 62.5 µg / mL, there was no significant difference in the incidence of renal edema, but the incidence of renal edema in the rhizomes of the genus Atractylodes lancea was the lowest; (3) at 125 µg / mL, the incidence of renal edema in the rhizomes of the genus Atractylodes lancea was significantly lower than that in the branches and leaves of the genus Atractylodes lancea. P < 0.05), the incidence of renal edema in rhizomes of Hengjingxi was significantly lower than that in seeds of Hengjingxi ( P < 0.001), the incidence of renal edema in the branches and leaves of the horizontal tree was significantly lower than that in the seeds of the horizontal tree ( P < 0.01). The lower the incidence of renal edema, the better the renal protection effect, suggesting that the rhizome of the horizontal meridian mat is the best for reducing the incidence of renal edema, followed by the branches and leaves of the horizontal meridian mat.

[0031] The three samples of A. truncatum were compared at the same concentration and showed the following effects on promoting glomerular filtration rate: (1) At 31.2 µg / mL, there was no significant difference in the fluorescence intensity of zebrafish, but the absolute value of the fluorescence intensity of A. truncatum branches and leaves was lower than that of A. truncatum rhizomes; (2) At 62.5 µg / mL, there was no significant difference in the fluorescence intensity of zebrafish, but the absolute value of the fluorescence intensity of A. truncatum seeds was the lowest, followed by A. truncatum rhizomes, and the highest was A. truncatum branches and leaves; (3) At 125 µg / mL, the fluorescence intensity of A. truncatum rhizomes was significantly lower than that of A. truncatum branches and leaves ( P < 0.01), the fluorescence intensity of the rhizome of the horizontal mat was significantly lower than that of the seeds of the horizontal mat ( P <0.001); the absolute value of the fluorescence intensity of the whole body of the seeds of the horizontal jing mat was significantly lower than that of the branches and leaves of the horizontal jing mat. The lower the whole body fluorescence intensity of the zebrafish, the better the effect of promoting glomerular filtration rate, indicating that the rhizome of the horizontal jing mat has the best effect in promoting glomerular filtration rate, followed by the seeds of the horizontal jing mat.

[0032] In summary, under the experimental conditions, the extract of the present invention has the effect of renal protection. The rhizomes and seeds of the rhizomes ...

[0033] Although the present invention has been described in detail above by general description, specific embodiments and tests, it is obvious to those skilled in the art that some modifications or improvements can be made on the basis of the present invention. Therefore, these modifications or improvements made on the basis of not departing from the spirit of the present invention belong to the scope of protection claimed by the present invention.

Claims

1. Application of a Herba Lycopodiellae Extract in kidney protection.

2. The use according to claim 1, characterized in that: The Hengjingxi extract is prepared by the following steps: taking the Hengjingxi medicinal material and crushing it, adding purified water to obtain the powder for slight boiling extraction, filtering, adding purified water to the residue to continue slight boiling extraction, filtering, combining the two extracts, adding cold boiled water for a certain amount, and obtaining the Hengjingxi extract.

3. The use according to claim 1, characterized in that: The Hengjingxi extract is prepared by the following steps: grinding the Hengjingxi medicinal material, adding 5 times the amount of purified water to the obtained powder for extraction, keeping it slightly boiling for 30 minutes, filtering, adding 2 to 3 times the amount of purified water to the residue to continue extraction, keeping it slightly boiling for 20 minutes, filtering, combining the two extracts, adding cold boiled water to quantify to 5 times the amount of the original powder, and obtaining the Hengjingxi extract.

4. The use according to claim 1, characterized in that: The Hengjingxi is the rhizome, branches, leaves or seeds of the Hengjingxi medicinal material.

5. The use according to claim 1, characterized in that: The specific performance of the kidney protection is that the rhizome and seeds of the Herba Lycopodii can reduce the incidence of renal edema and promote the glomerular filtration rate.

6. The use according to claim 1, characterized in that: The specific manifestation of the renal protection is that the branches and leaves of the Chinese medicine can reduce the incidence of renal edema, but the promotion of glomerular filtration rate is not obvious.